- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01154179
Appropriate Controlled Feeding: a Single Blinded Prospective Randomised Study
During patients' stay in the hospital, some of the patients may require artificial feeding for various reasons either through a vein or through a tube going directly to the gut. However, the amount of feeding that can be considered 'adequate' is unclear due to lack of research data. The current evidence the investigators have suggests that doctors might be giving patients more than they require, which might carry some risks. This hasn't been proven until now and there is no evidence as yet to show investigators exactly how much the doctors should feed patients.
The aim of the study is to see whether feeding patients less than what they are currently been feed is associated with better outcome.
The patients will be randomly (like tossing a coin) allocated into 2 groups. One group will get 100% of the current amount; the second group will get 60%. The investigators will then compare the groups to decide if feeding patients less than the current practice is associated with better outcomes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aims:
The primary aim of this study is to assess whether hypocaloric feeding in patients receiving artificial nutritional support is associated with reduced septic and non septic morbidity compared to "standard" nutritional support. Secondary end points will include the assessment of metabolic, physiological and clinical responses to the different feeding protocols.
ENTERAL FEEDING OBJECTIVES
- To investigate whether or not hypocaloric feeding in patients receiving enteral artificial nutritional support is associated with reduced septic and non septic morbidity compared to "standard" nutritional support.
- To investigate whether or not hypocaloric feeding in patients receiving enteral artificial nutritional support is associated with changes in the inflammatory response compared to "standard" nutritional support.
- To investigate whether or not hypocaloric feeding in patients receiving enteral artificial nutritional support is associated with changes in metabolic response compared to "standard" nutritional support.
- To investigate whether or not hypocaloric feeding in patients receiving enteral artificial nutritional support is associated with changes in nutrition status compared to "standard" nutritional support.
- To investigate whether or not hypocaloric feeding in patients receiving enteral artificial nutritional support is associated with differences in systemic complications compared to "standard" nutritional support.
- To undertake a cost benefit analysis in patients receiving enteral artificial nutritional support, with the assumption that patients receiving hypocaloric feeding will not necessarily manifest lower feeding costs.
PARENTERAL FEEDING OBJECTIVES
- To investigate whether or not hypocaloric feeding in patients receiving parenteral artificial nutritional support is associated with reduced septic and non septic morbidity compared to "standard" nutritional support.
- To investigate whether or not hypocaloric feeding in patients receiving parenteral artificial nutritional support is associated with changes in the inflammatory response compared to "standard" nutritional support.
- To investigate whether or not hypocaloric feeding in patients receiving parenteral artificial nutritional support is associated with changes in metabolic response compared to "standard" nutritional support.
- To investigate whether or not hypocaloric feeding in patients receiving parenteral artificial nutritional support is associated with changes in nutrition status compared to "standard" nutritional support.
- To investigate whether or not hypocaloric feeding in patients receiving parenteral artificial nutritional support is associated with differences in systemic complications compared to "standard" nutritional support.
- To undertake a cost benefit analysis in patients receiving parenteral artificial nutritional support, with the assumption that patients receiving hypocaloric feeding will not necessarily manifest lower feeding costs.
Study Design and Study Group:
This will be a single blind, randomized controlled clinical trial. All patients requiring adjuvant nutritional support will be included in this study. The need for nutritional support and the method of administration (enteral or parenteral) will be decided by the hospital's nutrition team as is present practice.
Clinically, patients requiring supplemental nutrition fall into two clinical groups. Those with a functional gut are fed enterally; the other group, whose gut, for whatever reason, is not functional are fed parenterally. This is the rationale of studying two groups of administration.
Please see Flowchart for exact details. Patients will enter into the parenteral or the enteral component of the stud y in a mutually exclusive manner with no crossover or randomisation occurring at this point. Thereafter, patients in either arm of the study (enteral or parenteral) will be randomised to one of two groups. Comparisons will be done within, but not across, each of the enteral and parenteral arms.
Enteral feeding details:
Enteral control group: patients will receive energy and protein intakes as recommended by the use of Schofield equations (TER=total energy requirements), as is current practice.
Enteral intervention group: patients will be prescribed 60% of recommended (by Schofield) requirements.
Parenteral feeding details:
Parenteral control group : the control group, will receive energy and protein intakes as recommended by the use of Schofield equations, as is current practice.
Parenteral intervention group: patients will be prescribed 60% of recommended (by Schofield) requirements.
Data analysis will be on an "intention to treat" basis. Enteral and parenteral study arms will be analysed separately.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Yorkshire
-
Scarborough, North Yorkshire, United Kingdom, YO12 6QL
- Scarborough General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All patients requiring artificial nutritional support in the hospital
Exclusion Criteria:
- Failure to obtain informed consent / assent from next of kin.
- Patients at risk of refeeding syndrome.
- If patients require concomitant enteral and parenteral nutrition.
- Pregnant women and children under the age of 18 years.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Normocaloric feeding
This control group will receive energy and protein intakes as recommended by the use of Schofield equations, as is current practice (100% of requirements)
|
This intervention group will be prescribed 60% of recommended (by Schofield) requirements.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Septic complication
Time Frame: average of one week
|
average of one week
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Inflammatory response
Time Frame: average of one week
|
average of one week
|
Metabolic response
Time Frame: average of one week
|
average of one week
|
Nutrition status
Time Frame: average of one week
|
average of one week
|
Systematic complications
Time Frame: average of one week
|
average of one week
|
Cost benefit analysis
Time Frame: average of one week
|
average of one week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Anwar E Owais, MBBS MRCSEd, Scarborough General Hospital
- Principal Investigator: Irfan Kabir, MRCS, SCarborough General hopital
- Principal Investigator: Marcel Gatt, MD, Scarborough General Hospital
- Principal Investigator: Claire Mcnaught, MD, Scarborough General Hospital
- Principal Investigator: John Macfie, MD, Scarborough General Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SNE-A01322
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients Requiring Artificial Nutrition
-
B. Braun Melsungen AGCompletedPatients Requiring Home Parenteral NutritionNetherlands, United Kingdom, France, Italy, Poland
-
Sustain, LLC of the American Society for Parenteral...Completed
-
Coram Clinical TrialsActive, not recruitingMalnutrition | Patients Requiring Home Parenteral NutritionUnited States
-
Limacorporate S.p.aActive, not recruiting
-
University Hospital Center of MartiniqueCentre Hospitalier Universitaire Dijon; University Hospital, Limoges; Assistance... and other collaboratorsCompletedPatients Requiring Cardiac SurgeryFrance
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedPatients Requiring Forefoot SurgeryUnited Kingdom
-
Damascus UniversityCompletedOrthodontic Patients Requiring Canine RetractionSyrian Arab Republic
-
University of LiegeCompletedPatients Requiring Mandible Orthodontic TreatmentBelgium
-
EarlySense Ltd.WithdrawnPost Operative Patient | Patients Requiring PCA | Respiratory Patients | Patients in Risk of FallUnited States
-
The Royal Bournemouth HospitalUnknownPatients Requiring Diagnostic Gastroscopy With SedationUnited Kingdom
Clinical Trials on Hypocaloric feeding
-
Wolfson Medical CenterUnknown
-
Agricultural University of AthensLaikο General Hospital, AthensRecruitingNon-Alcoholic Fatty Liver DiseaseGreece
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompletedObesity | Kidney StonesBrazil
-
Elisa Barron-CabreraRecruitingInflammation | Obesity | Physical Activity | Resistance ExerciseMexico
-
University of MinnesotaAmerican Diabetes AssociationCompletedType 2 Diabetes Mellitus | Insulin ResistanceUnited States
-
Lafrancol S.A.Hospital Universitario San IgnacioCompleted
-
roberta cazzolaIstituti Clinici di Perfezionamento di Milano; Luigi Sacco University HospitalCompletedMetabolic Syndrome | Obesity, Metabolically BenignItaly
-
University of AarhusArla Foods; Mejeribrugets ForskningsFond; Innovation foundationCompletedProtein MetabolismDenmark
-
Virginia Polytechnic Institute and State UniversityCompleted
-
Heidelberg UniversityCompleted